D.L. Olivera
Impact in
-
- Bone and Joint Diseases
- Bone health and osteoporosis research
- Genetics top 10%
- Mesenchymal stem cell research
Papers in
- Oncology 7
- Cytokine Signaling Pathways and Interactions 4
- Bone health and treatments 3
- Cancer Cells and Metastasis 2
-
- Bone Metabolism and Diseases 3
- Co-authors
- Maxine Gowen (3 shared papers)Mark Nuttall (2 shared papers)Amanda J. Patton (1 shared paper)Daniel P. Nadeau (1 shared paper)A M Badger (7 shared papers)Klaus Esser (1 shared paper)Ian E. James (2 shared papers)James E. Talmadge (2 shared papers)
- Journals
- Journal of Bone and Mineral Research (2 papers)Inflammation Research (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Bone (1 paper)Osteoporosis International (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
D.L. Olivera
12 papers receiving 455 citations
Peers
Comparison fields: 5 of 73
- Orthopedics and Sports Medicine 104
- Genetics 104
- Rheumatology 105
- Oncology 114
- Molecular Biology 248
Countries citing papers authored by D.L. Olivera
This map shows the geographic impact of D.L. Olivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.L. Olivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.L. Olivera more than expected).
Fields of papers citing papers by D.L. Olivera
This network shows the impact of papers produced by D.L. Olivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.L. Olivera. The network helps show where D.L. Olivera may publish in the future.
Co-authors
The 25 scholars most cited alongside D.L. Olivera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 294 | |
| 2 | 1996 | 50 | |
| 3 | Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock. | 1994 | 35 |
| 4 | Protective effect of SK&F 86002, a novel dual inhibitor of arachidonic acid metabolism, in murine models of endotoxin shock: inhibition of tumor necrosis factor as a possible mechanism of action. | 1989 | 29 |
| 5 | 2014 | 18 | |
| 6 | Beneficial effects of long-term treatment with SK&F 105685 in murine lupus nephritis. | 1990 | 16 |
| 7 | 1991 | 9 | |
| 8 | 1993 | 9 | |
| 9 | 1993 | 5 | |
| 10 | 1990 | 4 | |
| 11 | 1995 | 2 | |
| 12 | Inhibition of lymphoproliferative responses by SK&F 105685, a novel anti-arthritic agent. | 1991 | 1 |
About D.L. Olivera
D.L. Olivera is a scholar working on Oncology, Molecular Biology, Organic Chemistry, Pharmacology and Rheumatology, having authored 12 papers that have together received 472 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (4 papers), Bone health and treatments (3 papers), Bone Metabolism and Diseases (3 papers), Immune Response and Inflammation (2 papers), Cancer Cells and Metastasis (2 papers), Systemic Lupus Erythematosus Research (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Bone health and osteoporosis research (1 paper). The work is most often cited by research in Orthopedics and Sports Medicine (104 citations), Genetics (104 citations), Rheumatology (105 citations), Oncology (114 citations) and Molecular Biology (248 citations). D.L. Olivera has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Maxine Gowen, Mark Nuttall, Amanda J. Patton, Daniel P. Nadeau, A M Badger, Klaus Esser, Ian E. James, James E. Talmadge, Robert A. Dodds and Nazeeh Hanna. Their work appears in journals such as Journal of Bone and Mineral Research, Inflammation Research, Journal of Pharmacology and Experimental Therapeutics, Bone and Osteoporosis International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.